Besponsa (Inotuzumab ozogamicin)

Besponsa (Inotuzumab ozogamicin) is an targeted cancer therapy used to treat certain types of leukemia, a blood cancer. It combines a monoclonal antibody, which recognizes cancer cells, with a powerful chemotherapy drug. When administered, it binds specifically to leukemia cells with a particular marker, delivering the drug directly to them and destroying their ability to grow and multiply. This targeted approach helps minimize damage to healthy cells and improves treatment effectiveness for patients with advanced leukemia.